ArticleJournal of enzyme inhibition and medicinal chemistry2019

Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers.

Caolin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.